BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4 + T Cells

BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4 + T Cells

Tuberculosis (TB) is a major global public health problem causing significant mortality and morbidity. In addition to ~10.4 million cases of active TB annually, it is estimated that about two billion people are latently infected with ( ), the causative agent of TB. Reactivation of latent infection i...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2019-03, Vol.10, p.532-532
Main Authors: Sathkumara, Harindra D, Pai, Saparna, Aceves-Sánchez, Michel de Jesús, Ketheesan, Natkunam, Flores-Valdez, Mario Alberto, Kupz, Andreas
Format: Article
Language:eng
Subjects:
BCG
BCGΔBCG1419c
CD4 T cells
Immunology
reactivation
tuberculosis
vaccines
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tuberculosis (TB) is a major global public health problem causing significant mortality and morbidity. In addition to ~10.4 million cases of active TB annually, it is estimated that about two billion people are latently infected with ( ), the causative agent of TB. Reactivation of latent infection is the leading cause of death in patients with immunodeficiency virus (HIV) infection. The low efficiency of the only licensed anti-TB vaccine, Bacille Calmette-Guérin (BCG) to reduce pulmonary TB in adults contributes to this problem. Here we investigated if vaccination with conventional BCG or the genetically modified experimental BCGΔBCG1419c strain can prevent reactivation of latent lymphatic TB in a mouse model of induced reactivation, following the depletion of CD4 T cells, as it occurs in HIV individuals. Vaccination with conventional BCG or BCGΔBCG1419c prevented reactivation of from the infected lymph node and the systemic spread of to spleen and lung. Prevention of reactivation was independent of vaccination route and was accompanied by reduced levels of circulating inflammatory cytokines and the absence of lung pathology. Our results demonstrate that vaccine-induced CD4 T cells are not essential to prevent reactivation of latent lymphatic murine TB, and highlight the need to better understand how non-CD4 immune cell populations participate in protective immune responses to control latent TB.
ISSN:1664-3224
1664-3224